同步的双重原发性癌症复杂,严重的高血症
Martim Alçada1, Vasco Gaspar2, Guilherme Cunha3
1Internal Medicine, Hospital Distrital Santarém, Santarém, PRT.
Cureus
|September 29, 2023
概括
恶性血 (HCM) 是晚期癌症的一个严重迹象. 这一案例表明,骨解质性骨病变和瘤分泌与甲状腺激素相关的蛋白质如何导致严重的HCM.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 恶性血症 (HCM) 是一种关键的瘤紧急情况,与晚期疾病和不良预后有关.
- 早期识别和管理HCM对于患者的治疗结果至关重要.
研究的目的:
- 报告一种罕见的同时出现喉癌和前列腺癌的罕见病例,呈现出严重的高血症.
- 调查该患者高血症的多因素原因,包括骨解病变和副甲状腺激素相关蛋白质 (PTHrP) 分泌.
- 强调在患有高血症的患者中考虑多种恶性瘤和多种病因的重要性.
主要方法:
- 一个55岁男性的病例研究,患有高血症的症状,包括精神状态变化和便秘.
- 诊断工作包括体检,实验室测试 (血清,PSA),成像 (骨扫描) 和活检.
- 治疗包括用于高血症和管理已识别的恶性瘤的帕米德罗纳酸.
主要成果:
- 这名患者出现了严重的高血症 (18.9 mg/dl) 和前列腺特异性抗原升高 (319.18 ng/ml).
- 诊断包括喉状细胞癌与骨解性骨转移和前列腺腺癌.
- 用帕米德罗纳酸治疗有效地控制了高血症. 瘤中PTHrP的分泌被确定为一个促成因素.
结论:
- 这一案例凸显了在患有高血症的患者中高度怀疑恶性瘤的关键需求.
- 它强调了并发原发性恶性瘤的可能性和PTHrP在HCM中的作用.
- 对这些复杂性的认识对于有效的患者管理和改善结果至关重要.
更多相关视频
相关概念视频
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
02:30Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
02:18Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K